Validation of Patient Reported Outcome Measures for Use in Vulvodynia
1 other identifier
observational
20
1 country
4
Brief Summary
The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2019
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 10, 2018
CompletedStudy Start
First participant enrolled
February 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2019
CompletedOctober 28, 2019
October 1, 2019
7 months
November 29, 2018
October 25, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Validation of mVPAQ
Cognitive debrief and usability through interviews and completion of an electronic diary
1 week
Validation of mFSFI
Cognitive debrief and usability through interviews and completion of an electronic diary
1 week
Validation of Pain on Intercourse Numeric Rating Scale (NRS)
Cognitive debrief and usability through interviews and completion of an electronic diary. Pain on Intercourse NRS that describes pain experienced during this sexual intercourse episode by number. The higher is the number the worse is pain.
1 week
Secondary Outcomes (1)
Vulvar pain NRS
1 week
Eligibility Criteria
Subjects referred by clinicians
You may qualify if:
- Fluent in understanding, speaking and reading US-English
- Have vulvodynia with pain for at least 6 months
You may not qualify if:
- Clinically significant history of alcohol/drug abuse or dependence within the last 2 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ipsenlead
Study Sites (4)
San Diego Sexual Medicine
San Diego, California, 92120, United States
Center for Vulvovaginal Disorders
Washington D.C., District of Columbia, 20037, United States
Omaha OB-GYN Associates, PC
Omaha, Nebraska, 68130, United States
The Center for Vulvovaginal Disorders
New York, New York, 10036, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ipsen Medical Director
Ipsen
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 10, 2018
Study Start
February 18, 2019
Primary Completion
September 19, 2019
Study Completion
September 19, 2019
Last Updated
October 28, 2019
Record last verified: 2019-10